SCA Pharmaceuticals, Windsor, CT

Is SCA Pharmaceuticals an FDA-registered 503B outsourcing facility?

Yes. FDA’s registered outsourcing facility list, updated Nov 6, 2026, names SCA Pharmaceuticals in Windsor, CT, first registered Aug 3, 2017 and most recently registered Oct 26, 2026. FDA lists its last inspection as Mar 13, 2026, with a Form FDA 483 issued; FDA lists the action on that inspection as “Response Letter Issued 10/19/2026”.

FDA registers outsourcing facilities under section 503B; state boards of pharmacy issue pharmacy licenses separately. FDA’s list does not say which drugs a facility makes.

Location on FDA’s list
Windsor, CT
Initial registration
Aug 3, 2017
Most recent registration
Oct 26, 2026
Last inspection
Mar 13, 2026
Form 483 issued at last inspection
Yes
Recall after last inspection
No
Action on last inspection
Response Letter Issued 10/19/2026
Intends to compound sterile drugs from bulk substances
Yes

FDA inspections and actions on record

No entry for this facility was matched on FDA’s compounding inspections and actions page (current as of Oct 22, 2026). FDA may list it under a different name, and the page covers actions from 2019 on.

FDA inspection classifications and published Form 483s

No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.

The dashboard does list SCA Pharmaceuticals, LLC, Windsor, CT (FEI 3013736415): same name and state, different city, so not treated as this site.

GLP-1 records in this index

No FDA warning letter or recall report naming a GLP-1 drug in this index, as of Nov 15, 2026, is addressed to this facility’s exact legal name (SCA Pharmaceuticals). That is not a finding beyond this index’s search.

The SCA Pharmaceuticals pharmacy page answers whether it has had a state board action or FDA letter, from the same FDA lists.

FDA’s 503B list also names SCA Pharmaceuticals, Little Rock, AR. Each is a separate listing with its own records; a similar name does not show they are the same firm.

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.